|
Phase III |
Combination Chemotherapy in Treating Women With Breast Cancer |
2009-05-20 |
|
Phase II |
Gefitinib Plus Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Bladder Cancer |
2009-05-20 |
|
Phase III |
Isotretinoin With or Without Monoclonal Antibody, Interleukin-2, and Sargramostim Following Stem Cell Transplantation in Treating Patients With Neuroblastoma |
2009-05-20 |
|
Phase III |
Cyclophosphamide and Prednisone With or Without Immunoglobulin in Treating Abnormal Muscle Movement in Children With Neuroblastoma |
2009-05-20 |
|
Phase III |
Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-Small Cell Lung Cancer |
2009-05-20 |
|
Phase I |
Radiolabeled Monoclonal Antibody Therapy Combined With Total-Body Irradiation, Allogeneic Peripheral Stem Cell Transplantation, and Immunosuppression Therapy in Treating Older Patients Who Have Advanced Acute Myeloid Leukemia, Myelodysplastic Syndrome, or |
2009-05-20 |
|
Phase III |
Cytarabine and Daunorubicin With or Without Gemtuzumab Ozogamicin Followed By High-Dose Cytarabine Followed By Either Gemtuzumab Ozogamicin or No Additional Therapy in Treating Patients With Previously Untreated De Novo Acute Myeloid Leukemia |
2009-05-20 |
|
Phase I |
Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer |
2009-05-20 |
|
Phase III |
Anastrozole With or Without Fulvestrant as First-Line Therapy in Treating Postmenopausal Women With Metastatic Breast Cancer |
2009-05-20 |
|
Phase III |
Comparison of Entecavir to Adefovir in Chronic Hepatitis B Virus (HBV) Patients With Hepatic Decompensation |
2009-05-20 |
|
Phase III |
Erlotinib or Placebo Following Chemoradiotherapy (Chemo/RT) in Stage III Non-Small Cell Lung Cancer (NSCLC) |
2009-05-20 |
|
Phase I |
Safety Study of EMD 72000 in Combination With ECX (Epirubicin, Cisplatin and Capecitabine) in Oesophagogastric Cancer |
2009-05-20 |
|
Phase I |
A Study of Paclitaxel and Carboplatin in Combination With Bexarotene Oral Capsules in Patients With Advanced Lung Cancer |
2009-05-20 |
|
|
An Expanded Access Study of Oral Liquid Efavirenz in the Treatment of Children With HIV Infection |
2009-05-20 |
|
Phase I |
Pharmacokinetics of Efavirenz in HIV-1 Infected Subjects With Hepatic Impairment |
2009-05-20 |
|
Phase III |
Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer |
2009-05-20 |
|
|
Safety, Tolerability, and Blood Levels of Ritonavir-Boosted Atazanavir and Rifampin When Taken Together in HIV Uninfected Adults |
2009-05-20 |
|
Phase III |
Comparison of Fulvestrant (FASLODEXâ„¢) 250 mg and 500mg in Postmenopausal Women With Oestrogen Receptor Positive Advanced Breast Cancer Progressing or Relapsing After Previous Endocrine Therapy. |
2009-05-20 |
|
Phase III |
A Companion Study for Patients Enrolled in Prior/Parent Ipilimumab Studies |
2009-05-20 |
|
Phase I |
Docetaxel and Carboplatin Followed by Oral Capecitabine, Docetaxel and Radiation for Esophageal Cancer |
2009-05-20 |
|
Phase II |
Clinical Trial Characterizing the Bioavailability of 1-Octanol in Adults With Ethanol-Responsive Essential Tremor |
2009-05-20 |
|
Phase III |
Chronic Myelogenous Leukemia (CML) - Follow on: Study of BMS-354825 in Subjects With CML |
2009-05-20 |
|
Phase III |
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia |
2009-05-20 |
|
Phase II |
Effectiveness of Fluoxetine in Young People for the Treatment of Major Depression and Marijuana Dependence |
2009-05-20 |
|
Phase I |
17-N-Allylamino-17-Demethoxygeldanamycin and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, Chronic Myelomonocytic Leukemia, or Myelodysplastic Syndromes |
2009-05-20 |